USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS CAUSED BY TREATMENT WITH A MEK INHIBITOR

摘要

The present technology relates to compositions comprising BRAF inhibitors and uses thereof for treating and/or preventing a MEK inhibitor-associated cutaneous condition in a subject. Kits for use in practicing the methods are also provided.